![Inabata](https://www.pharmacompass.com/image/flap/inabata-corp-desktop-header-w26gif-37454.gif)
![Inabata](https://www.pharmacompass.com/image/flap/inabata-corp-mobile-header-w26gif-18803.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.mithra.com/en/mithra-sells-estetra-srl-neuralis-sa-and-specific-assets-to-gedeon-richter/
https://www.mithra.com/en/mithra-files-for-bankruptcy-and-continues-negotiations-with-gedeon-richter-for-the-sale-of-neuralis-and-estetra/
https://www.mithra.com/en/mithra-applies-for-extension-of-court-protection-measures-to-advance-monetization-process/
https://www.mithra.com/en/mithra-receives-additional-eur-2-5-million-to-advance-monetization/
https://www.mithra.com/en/mithra-announces-grant-of-two-additional-u-s-patents-for-nextstellis/
https://www.mithra.com/en/mithra-enters-into-exclusive-negotiations-with-gedeon-richter-and-secures-continued-funding-in-the-context-of-its-monetization-process/
https://www.mithra.com/en/mithra-updates-on-offers-received-in-the-context-of-its-monetization-process-and-on-its-annual-report-2023/
https://www.mithra.com/en/early-data-from-mithras-estelle-pediatric-study-to-be-presented-at-two-upcoming-congresses/
https://www.mithra.com/en/mithra-announces-updates-to-its-2024-financial-calendar/
https://www.mithra.com/en/mithra-updates-on-its-ongoing-monetization-process/